Boulder, CO – InDevR, Inc., an innovative biotechnology company dedicated to improving diagnostics and vaccine manufacturing, today announced the formation of the InDevR Strategic Advisory Board, an esteemed group of scientific and business leaders chosen to counsel the company on the opportunities for maximizing the impact of its technologies globally. Kathy Rowlen, Ph.D., Chief Executive […]
Schlieren, Switzerland — The United States Patent and Trademark Office (USPTO) has officially granted InSphero AG full protection of its GravityPLUS™ hanging drop technology. InSphero, the world’s leading developer of easy-to-use solutions for organotypic 3D cell culture models and body-on-a-chip systems, now holds hanging drop patents in the world’s major pharmaceutical and biotechnology markets, including […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months. On August 11, 2015, Sigma-Aldrich and Merck announced they had obtained all necessary antitrust approvals, with the approval of […]
Goettingen, Germany — Next to the quickly established state-of-the-art molecular diagnostic products manufactured by AmoyDx, MoBiTec GmbH, Germany, is offering a unique cancer cell detection probe: ProteoGREEN™-gGlu Developed and manufactured by Japan’s Goryo Chemicals, Inc., (https://goryochemical.com), the fluorogenic probe ProteoGREEN™-gGlu constitutes one of the easiest means to detect and image cancer cells by fluorescence microscopy […]
CARLSBAD, Calif. — The bioproduction industry now has access to a new serum replacement for immune cell culture that helps minimize supply and safety risks that have been persistent problems for development of cell therapeutics. The GIBCO CTS Immune Cell SR can be used with many base media in less time, with lower costs and […]
Horizon Discovery Group plc Enters Bioproduction Cell Line Licensing Agreement with LakePharma, Inc.
Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”), the international life science company supplying research tools and services that power genomics research and the development of personalized medicines, today announces that its Bioproduction business has signed a license agreement with LakePharma, Inc., a leading contract research organization (CRO). The terms of the license cover […]
CARLSBAD, Calif. — Biopharmaceutical companies developing protein-based therapeutics now have access t o a new t ransient CHO expression syst em designed t o great ly enhance early phase drug screening. The Gibco ExpiCHO Expression System is a fully redesigned transient expression system that enables biologics developers to produce proteins in CHO cells from discovery […]
Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the international life science company supplying research tools and services that power genomics research and the development of personalised medicines, and Abcam plc (AIM: ABC), a global leader in the supply of research antibodies, today announced the formation of a license and supply […]
SANTA CLARA, Calif., and BILLERICA, Mass. — Agilent Technologies Inc. (NYSE: A) and Seahorse Bioscience today announced they have signed a definitive agreement under which Agilent will acquire Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Exploration into cell metabolism is rapidly accelerating as the links between […]
The DeltaVision™ OMX SR system from GE Healthcare’s Life Sciences business is a compact multimode imaging platform that delivers super-resolution images of live cells, for physiologically relevant results. DeltaVision OMX SR is designed to ensure precision alignment and stability for reliable super-resolution imaging. Its stable multichannel imaging has been specifically optimized to provide high-quality images […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
